Physician profile
Mark J Jostes
NPI 1477518595
$4,828.71
in general payments reported to CMS, 2019-2025
36 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $972 · 2020: $423 · 2021: $1,100 · 2022: $507 · 2023: $1,026 · 2024: $613 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,826.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,093.83 | 2019-2025 | |
| Astellas Pharma US INC | $423.75 | 2019-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $282.22 | 2020-2025 | Slynd |
| Agile Therapeutics, INC. | $272.28 | 2021-2024 | Twirla |
| Amgen INC. | $272.24 | 2019-2024 | Evenity, Prolia |
| Pfizer INC. | $227.02 | 2019-2024 | |
| Therapeuticsmd, INC. | $215.43 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $207.72 | 2023-2025 | Myfembree, Gemtesa |
| Sage Therapeutics, LLC | $192.77 | 2024-2025 | Zurzuvae |
| Avion Pharmaceuticals | $165.57 | 2020-2023 | Balcoltra |
| Shield Therapeutics INC | $163.30 | 2023-2024 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $145.57 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $131.58 | 2021-2024 | |
| Urovant Sciences INC | $124.99 | 2021 | |
| Myovant Sciences INC. | $123.50 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $108.93 | 2021-2025 | Phexxi, Solosec, Phexx |
| Hologic Sales and Service, LLC | $93.97 | 2019-2022 | |
| Mission Pharmacal Company | $74.63 | 2019-2020 | |
| Lupin INC. | $53.32 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $48.62 | 2022 | |
| Vertical Pharmaceuticals, LLC | $44.69 | 2019 | |
| Organon LLC | $44.46 | 2024-2025 | Nexplanon |
| Amag Pharmaceuticals, INC. | $37.43 | 2019-2020 | |
| Minerva Surgical, INC | $32.40 | 2023 | |
| Duchesnay USA Incorporated | $30.70 | 2019 | |
| Allergan, INC. | $27.50 | 2019 | |
| Meditrina | $26.13 | 2023 | |
| Channel Medsystems, INC. | $24.71 | 2022 | |
| Ascend Therapeutics US, LLC | $20.34 | 2023 | |
| Lilly USA, LLC | $20.16 | 2025 | Zepbound |
| Exact Sciences Corporation | $18.36 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $18.22 | 2019 | |
| Aspira Women'S Health INC | $16.62 | 2021 | |
| Medtronic, INC. | $16.17 | 2023 | Truclear |
| Virtus Pharmaceuticals LLC | $15.09 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Jostes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.